Summary of Study ST001491

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001009. The data can be accessed directly via it's Project DOI: 10.21228/M88H6T This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001491
Study TitleGlobal Urine Metabolic Profiling to Predict Gestational Age in Term and Preterm Pregnancies
Study SummaryAssessment of gestational age (GA) is key to provide optimal care during pregnancy. However, its accurate determination remains challenging in low- and middle-resource countries, where access to obstetric ultrasound is limited. Hence, there is an urgent need to develop clinical approaches that allow accurate and inexpensive estimation of GA. We investigated the ability of urinary metabolites to predict GA at time of collection in a diverse multi-site cohort (n = 99) using a broad-spectrum liquid chromatography coupled with mass spectrometry (LC-MS) platform. Our approach detected a myriad of steroid hormones and their derivatives including estrogens, progesterones, corticosteroids and androgens that associated with pregnancy progression. We developed a prediction model that predicted GA with high accuracy using the levels of three metabolites (rho = 0.87, .RMSE = 1.58 weeks). These predictions were robust irrespective of whether the pregnancy went to term or ended prematurely. Overall, we demonstrate the feasibility of implementing urine collection for metabolomics analysis in large-scale multi-site studies and we report a predictive model of GA with a potential clinical value.
Institute
Stanford University
Last NameContrepois
First NameKevin
Address300 Pasteur Dr
Emailkcontrep@stanford.edu
Phone6506664538
Submit Date2020-09-27
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2022-05-16
Release Version1
Kevin Contrepois Kevin Contrepois
https://dx.doi.org/10.21228/M88H6T
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Collection:

Collection ID:CO001560
Collection Summary:The study comprises a single urine sample for each participant (n = 99) that was collected at a prenatal visit after ultrasound confirmed a gestation < 20 weeks. Ultrasound imaging was performed by trained sonologists in compliance with standard-of-care. All study sites employed a uniform method of GA assessment, urine collection and handling. Urine samples were aliquoted and frozen at -80°C within 2 hours. Deidentified urine aliquots were shipped on dry ice from each biorepository to Stanford University as a single batch and under continuous temperature monitoring. Urine samples from 20 healthy pregnancies collected between 8 and 19 weeks of gestation at the Lucile Packard Children’s Hospital at Stanford University, served as the validation cohort.
Sample Type:Urine
Storage Conditions:-80℃
  logo